These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9717164)

  • 1. [The importance of other classical pyogenic pathogens (Staphylococcus aureus, gram negative bacteria and others) in community acquired pneumonia].
    Pachón J; Cordero E; Caballero FJ
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():65-70. PubMed ID: 9717164
    [No Abstract]   [Full Text] [Related]  

  • 2. Respiratory infections due to drug-resistant bacteria.
    Song JH; Chung DR
    Infect Dis Clin North Am; 2010 Sep; 24(3):639-53. PubMed ID: 20674796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal community-acquired pneumonia: pathogens and treatment.
    Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D
    J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of sputum gram stain and culture.
    Musher DM
    Arch Intern Med; 2005 Feb; 165(4):470-1. PubMed ID: 15738381
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nonresolving and progressive pneumonia.
    Menéndez R; Perpiñá M; Torres A
    Semin Respir Infect; 2003 Jun; 18(2):103-11. PubMed ID: 12840791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of community-acquired pneumonia treated at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Tantiwong P
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):355-61. PubMed ID: 12236437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department management of community-acquired methicillin-resistant Staphylococcus aureus.
    Kilbane BJ; Reynolds SL
    Pediatr Emerg Care; 2008 Feb; 24(2):109-14; quiz 115-7. PubMed ID: 18277849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline for nursing home acquired pneumonia (NHAP).
    Cunha BA
    Scand J Infect Dis; 2009; 41(1):77-8, author reply 76. PubMed ID: 18821134
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques.
    Manali E; Papadopoulos A; Tsiodras S; Polychronopoulos V; Giamarellou H; Kanellakopoulou K
    Scand J Infect Dis; 2008; 40(4):286-92. PubMed ID: 17918018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory community-acquired pneumonia: the predominance of atypical pathogens.
    Cunha BA
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):579-83. PubMed ID: 14649230
    [No Abstract]   [Full Text] [Related]  

  • 15. Staphylococcus aureus pneumonia: emergence of MRSA in the community.
    Bradley SF
    Semin Respir Crit Care Med; 2005 Dec; 26(6):643-9. PubMed ID: 16388433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
    Morrissey I; Ge Y; Janes R
    Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia.
    Stein RT; Marostica PJ
    Paediatr Respir Rev; 2006; 7 Suppl 1():S136-7. PubMed ID: 16798540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
    Roveta S; Marchese A; Debbia EA
    Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A position paper on the treatment of hospital acquired pneumonia (HAP): do we need guidelines?
    Ramphal R
    Acta Clin Belg; 2002; 57(4):202-6. PubMed ID: 12462796
    [No Abstract]   [Full Text] [Related]  

  • 20. Community acquired pneumonia and treatment priorities.
    Jagminas L
    Med Health R I; 2000 Dec; 83(12):396-8. PubMed ID: 11190130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.